In the current study, we provide the first evidence that the regulation of cell survival, proliferation and rate of tumor growth in early (LNCaP) and advanced prostate cancer (PC3 and DU145) cells are predominantly dependent on GSK3α. The gene discussed is GSK3A; the disease is neoplasm.